Home » Topics » BioWorld Asia

BioWorld Asia
RSS

Core Group Losses Up; On Plan, Company Says

Sep. 30, 1998

D-Pharm Buys Lipid 'Tag' Rights From Oregon Firm

Sep. 30, 1998

Biovector Planning IPO For 'At Least' FFr200M

Sep. 23, 1998

Enzyme Structure Reveals Tumor Suppressor Function

Sep. 23, 1998

Cerebrus, Lilly Team Up To Treat Chemo Emesis

Sep. 23, 1998

Novartis Scientists Form Company To Target CNS

Sep. 23, 1998

ExonHit, Rhone-Poulenc Target Tumor Suppressors

Sep. 23, 1998

Irish Biotech Starving For Cash, Leaders Say

Sep. 23, 1998

Cortecs Trims Spending, Denies Financing Rumors

Sep. 23, 1998

Vanguard To Drop Drugs After Phase II Studies

Sep. 23, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...